Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

Pfizer

Status and phase: Completed; Phase 3

Conditions: Growth Disorder

Treatments: Drug: Treatment with Genotropin in different dosages

Study type: Interventional

Funder types: Industry

Identifiers

NCT00174421

98-8122-011

A6281219

Details and patient eligibility

About

This trial evaluates whether long-term treatment with Genotropin normalizes final (adult) height in short children born small for gestational age

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participation in the 90-080 study

Exclusion criteria

• Any severe, acute or chronic disease
• Any other identifiable reason for short stature

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)